Gary Dubin

Nessuna posizione attualmente

69 anni

Health Technology

Consumer Services

Profilo

Gary Dubin formerly worked at HilleVax, Inc., as Independent Director from 2022 to 2025, Takeda Pharmaceuticals U.S.A., Inc., as President-Vaccine Business, GlaxoSmithKline Vaccines Srl, as VP & Head-Late Clinical Development from 2010 to 2015, and the University of Pennsylvania, as Assistant Professor.
Dr. Dubin received his doctorate degree from the University of Pennsylvania.

Precedenti posizioni note di Gary Dubin

Società	Posizione	Fine
HILLEVAX, INC.	Direttore/Membro del Consiglio	17/09/2025
Glaxosmithkline Vaccines Srl Glaxosmithkline Vaccines Srl BiotechnologyHealth Technology Develops, manufactures and distributes vaccines	Corporate Officer/Principal	01/01/2015
Takeda Pharmaceuticals U.S.A., Inc. Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals	Corporate Officer/Principal	-
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Gary Dubin

Formazione di Gary Dubin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private